NEWS
Type 1 diabetes prevention: First young participant reaches turning point in POInT study
Eddie from Saxony is our first POInT participant to start the observation phase. © CRTD Center for Regenerative Therapies TU Dresden
Halftime: The world’s largest prevention study for type 1 diabetes in infants has reached an important milestone
One of the largest research collaborations on type 1 diabetes in Europe has reached an important milestone.
6th GPPAD Investigator Meeting
The international GPPAD team met in Warsaw to take part in workshops, exchange information about ongoing studies, and discuss future plans.
